-
1
-
-
76549129820
-
Drug combination studies and their synergy quantification using the Chou-Talalay method
-
10.1158/0008-5472.CAN-09-1947, 20068163
-
Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010, 70(2):440-446. 10.1158/0008-5472.CAN-09-1947, 20068163.
-
(2010)
Cancer Res
, vol.70
, Issue.2
, pp. 440-446
-
-
Chou, T.C.1
-
2
-
-
77950608347
-
Microtubule targeting agents: from biophysics to proteomics
-
10.1007/s00018-009-0245-6, 20107862
-
Calligaris D, Verdier-Pinard P, Devred F, Villard C, Braguer D, Lafitte D. Microtubule targeting agents: from biophysics to proteomics. Cell Mol Life Sci 2010, 67(7):1089-1104. 10.1007/s00018-009-0245-6, 20107862.
-
(2010)
Cell Mol Life Sci
, vol.67
, Issue.7
, pp. 1089-1104
-
-
Calligaris, D.1
Verdier-Pinard, P.2
Devred, F.3
Villard, C.4
Braguer, D.5
Lafitte, D.6
-
3
-
-
50349097617
-
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents
-
10.1016/j.ccr.2008.08.001, 2565587, 18772115
-
Shaked Y, Henke E, Roodhart JM, Mancuso P, Langenberg MH, Colleoni M, Daenen LG, Man S, Xu P, Emmenegger U. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008, 14(3):263-273. 10.1016/j.ccr.2008.08.001, 2565587, 18772115.
-
(2008)
Cancer Cell
, vol.14
, Issue.3
, pp. 263-273
-
-
Shaked, Y.1
Henke, E.2
Roodhart, J.M.3
Mancuso, P.4
Langenberg, M.H.5
Colleoni, M.6
Daenen, L.G.7
Man, S.8
Xu, P.9
Emmenegger, U.10
-
4
-
-
0035836793
-
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
-
10.1016/S0304-3835(01)00382-2, 11248417
-
Pourgholami MH, Woon L, Almajd R, Akhter J, Bowery P, Morris DL. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett 2001, 165(1):43-49. 10.1016/S0304-3835(01)00382-2, 11248417.
-
(2001)
Cancer Lett
, vol.165
, Issue.1
, pp. 43-49
-
-
Pourgholami, M.H.1
Woon, L.2
Almajd, R.3
Akhter, J.4
Bowery, P.5
Morris, D.L.6
-
5
-
-
17644414121
-
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis
-
10.1007/s00280-004-0927-6, 15565325
-
Pourgholami MH, Akhter J, Wang L, Lu Y, Morris DL. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother Pharmacol 2005, 55(5):425-432. 10.1007/s00280-004-0927-6, 15565325.
-
(2005)
Cancer Chemother Pharmacol
, vol.55
, Issue.5
, pp. 425-432
-
-
Pourgholami, M.H.1
Akhter, J.2
Wang, L.3
Lu, Y.4
Morris, D.L.5
-
6
-
-
33645661534
-
Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice
-
10.1158/1078-0432.CCR-05-1181, 16551879
-
Pourgholami MH, Yan Cai Z, Lu Y, Wang L, Morris DL. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice. Clin Cancer Res 2006, 12(6):1928-1935. 10.1158/1078-0432.CCR-05-1181, 16551879.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.6
, pp. 1928-1935
-
-
Pourgholami, M.H.1
Yan Cai, Z.2
Lu, Y.3
Wang, L.4
Morris, D.L.5
-
7
-
-
0018703882
-
The interaction of benzimidazole carbamates with mammalian microtobule protein
-
10.1016/0006-2952(79)90049-2, 518680
-
Ireland CM, Gull K, Gutteridge WE, Pogson CI. The interaction of benzimidazole carbamates with mammalian microtobule protein. Biochem Pharmacol 1979, 28(17):2680-2682. 10.1016/0006-2952(79)90049-2, 518680.
-
(1979)
Biochem Pharmacol
, vol.28
, Issue.17
, pp. 2680-2682
-
-
Ireland, C.M.1
Gull, K.2
Gutteridge, W.E.3
Pogson, C.I.4
-
8
-
-
0021839810
-
Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in vitro
-
10.1016/0006-2952(85)90611-2, 3985991
-
Lacey E, Watson TR. Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in vitro. Biochem Pharmacol 1985, 34(7):1073-1077. 10.1016/0006-2952(85)90611-2, 3985991.
-
(1985)
Biochem Pharmacol
, vol.34
, Issue.7
, pp. 1073-1077
-
-
Lacey, E.1
Watson, T.R.2
-
9
-
-
1942438028
-
Microtubules as a target for anticancer drugs
-
10.1038/nrc1317, 15057285
-
Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004, 4(4):253-265. 10.1038/nrc1317, 15057285.
-
(2004)
Nat Rev Cancer
, vol.4
, Issue.4
, pp. 253-265
-
-
Jordan, M.A.1
Wilson, L.2
-
10
-
-
0025341331
-
New colorimetric cytotoxicity assay for anticancer-drug screening
-
10.1093/jnci/82.13.1107, 2359136
-
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82(13):1107-1112. 10.1093/jnci/82.13.1107, 2359136.
-
(1990)
J Natl Cancer Inst
, vol.82
, Issue.13
, pp. 1107-1112
-
-
Skehan, P.1
Storeng, R.2
Scudiero, D.3
Monks, A.4
McMahon, J.5
Vistica, D.6
Warren, J.T.7
Bokesch, H.8
Kenney, S.9
Boyd, M.R.10
-
11
-
-
0032484528
-
Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule
-
10.1002/(SICI)1097-0215(19980105)75:1<57::AID-IJC10>3.0.CO;2-A, 9426691
-
Giannakakou P, Villalba L, Li H, Poruchynsky M, Fojo T. Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule. Int J Cancer 1998, 75(1):57-63. 10.1002/(SICI)1097-0215(19980105)75:1<57::AID-IJC10>3.0.CO;2-A, 9426691.
-
(1998)
Int J Cancer
, vol.75
, Issue.1
, pp. 57-63
-
-
Giannakakou, P.1
Villalba, L.2
Li, H.3
Poruchynsky, M.4
Fojo, T.5
-
12
-
-
84867000700
-
Complexation of Albendazole with Hydroxypropyl-beta-Cyclodextrin Significantly Improves its Pharmacokinetic Profile, Cell Cytotoxicity and Antitumor Efficacy in Nude Mice
-
Ehteda A, Galettis P, Chu SW, Pillai K, Morris DL. Complexation of Albendazole with Hydroxypropyl-beta-Cyclodextrin Significantly Improves its Pharmacokinetic Profile, Cell Cytotoxicity and Antitumor Efficacy in Nude Mice. Anticancer Res 2012, 32(9):3659-3666.
-
(2012)
Anticancer Res
, vol.32
, Issue.9
, pp. 3659-3666
-
-
Ehteda, A.1
Galettis, P.2
Chu, S.W.3
Pillai, K.4
Morris, D.L.5
-
13
-
-
2942685341
-
Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation
-
10.1093/jnci/djh168, 15199114
-
Stoeltzing O, McCarty MF, Wey JS, Fan F, Liu W, Belcheva A, Bucana CD, Semenza GL, Ellis LM. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004, 96(12):946-956. 10.1093/jnci/djh168, 15199114.
-
(2004)
J Natl Cancer Inst
, vol.96
, Issue.12
, pp. 946-956
-
-
Stoeltzing, O.1
McCarty, M.F.2
Wey, J.S.3
Fan, F.4
Liu, W.5
Belcheva, A.6
Bucana, C.D.7
Semenza, G.L.8
Ellis, L.M.9
-
14
-
-
27144486110
-
Beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells
-
10.1158/0008-5472.CAN-05-0088, 16230404
-
Gokmen-Polar Y, Escuin D, Walls CD, Soule SE, Wang Y, Sanders KL, Lavallee TM, Wang M, Guenther BD, Giannakakou P. beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells. Cancer Res 2005, 65(20):9406-9414. 10.1158/0008-5472.CAN-05-0088, 16230404.
-
(2005)
Cancer Res
, vol.65
, Issue.20
, pp. 9406-9414
-
-
Gokmen-Polar, Y.1
Escuin, D.2
Walls, C.D.3
Soule, S.E.4
Wang, Y.5
Sanders, K.L.6
Lavallee, T.M.7
Wang, M.8
Guenther, B.D.9
Giannakakou, P.10
-
15
-
-
75849159018
-
A theory of microtubule catastrophes and their regulation
-
10.1073/pnas.0910774106, 2795527, 19948965
-
Brun L, Rupp B, Ward JJ, Nedelec F. A theory of microtubule catastrophes and their regulation. Proc Natl Acad Sci USA 2009, 106(50):21173-21178. 10.1073/pnas.0910774106, 2795527, 19948965.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.50
, pp. 21173-21178
-
-
Brun, L.1
Rupp, B.2
Ward, J.J.3
Nedelec, F.4
-
16
-
-
0028808702
-
Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer
-
Hudes GR, Nathan FE, Khater C, Greenberg R, Gomella L, Stern C, McAleer C. Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. Semin Oncol 1995, 22(5 Suppl 12):41-45.
-
(1995)
Semin Oncol
, vol.22
, Issue.5 SUPPL. 12
, pp. 41-45
-
-
Hudes, G.R.1
Nathan, F.E.2
Khater, C.3
Greenberg, R.4
Gomella, L.5
Stern, C.6
McAleer, C.7
-
17
-
-
0027097763
-
Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer
-
Hudes GR, Greenberg R, Krigel RL, Fox S, Scher R, Litwin S, Watts P, Speicher L, Tew K, Comis R. Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. J Clin Oncol 1992, 10(11):1754-1761.
-
(1992)
J Clin Oncol
, vol.10
, Issue.11
, pp. 1754-1761
-
-
Hudes, G.R.1
Greenberg, R.2
Krigel, R.L.3
Fox, S.4
Scher, R.5
Litwin, S.6
Watts, P.7
Speicher, L.8
Tew, K.9
Comis, R.10
-
18
-
-
0026524697
-
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer
-
Seidman AD, Scher HI, Petrylak D, Dershaw DD, Curley T. Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer. J Urol 1992, 147(3 Pt 2):931-934.
-
(1992)
J Urol
, vol.147
, Issue.3 PART 2
, pp. 931-934
-
-
Seidman, A.D.1
Scher, H.I.2
Petrylak, D.3
Dershaw, D.D.4
Curley, T.5
-
19
-
-
0031446832
-
Docetaxel in combination with doxorubicin or vinorelbine
-
Dieras V, Fumoleau P, Kalla S, Misset JL, Azli N, Pouillart P. Docetaxel in combination with doxorubicin or vinorelbine. Eur J Cancer 1997, 33(Suppl 7):S20-22.
-
(1997)
Eur J Cancer
, vol.33
, Issue.SUPPL. 7
-
-
Dieras, V.1
Fumoleau, P.2
Kalla, S.3
Misset, J.L.4
Azli, N.5
Pouillart, P.6
-
20
-
-
0029021646
-
Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells
-
10.1093/jnci/87.14.1072, 7616599
-
Knick VC, Eberwein DJ, Miller CG. Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells. J Natl Cancer Inst 1995, 87(14):1072-1077. 10.1093/jnci/87.14.1072, 7616599.
-
(1995)
J Natl Cancer Inst
, vol.87
, Issue.14
, pp. 1072-1077
-
-
Knick, V.C.1
Eberwein, D.J.2
Miller, C.G.3
-
21
-
-
0029103212
-
Simultaneous combination of microtubule depolymerizing and stabilizing agents acts at low doses
-
10.1097/00001813-199508000-00006, 7579557
-
Garcia P, Braguer D, Carles G, Briand C. Simultaneous combination of microtubule depolymerizing and stabilizing agents acts at low doses. Anticancer Drugs 1995, 6(4):533-544. 10.1097/00001813-199508000-00006, 7579557.
-
(1995)
Anticancer Drugs
, vol.6
, Issue.4
, pp. 533-544
-
-
Garcia, P.1
Braguer, D.2
Carles, G.3
Briand, C.4
-
22
-
-
18844469806
-
Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines
-
Martello LA, McDaid HM, Regl DL, Yang CP, Meng D, Pettus TR, Kaufman MD, Arimoto H, Danishefsky SJ, Smith AB. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin Cancer Res 2000, 6(5):1978-1987.
-
(2000)
Clin Cancer Res
, vol.6
, Issue.5
, pp. 1978-1987
-
-
Martello, L.A.1
McDaid, H.M.2
Regl, D.L.3
Yang, C.P.4
Meng, D.5
Pettus, T.R.6
Kaufman, M.D.7
Arimoto, H.8
Danishefsky, S.J.9
Smith, A.B.10
-
23
-
-
3142723291
-
Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells
-
10.1158/0008-5472.CAN-04-0693, 15256469
-
Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Cancer Res 2004, 64(14):4957-4964. 10.1158/0008-5472.CAN-04-0693, 15256469.
-
(2004)
Cancer Res
, vol.64
, Issue.14
, pp. 4957-4964
-
-
Honore, S.1
Kamath, K.2
Braguer, D.3
Horwitz, S.B.4
Wilson, L.5
Briand, C.6
Jordan, M.A.7
-
24
-
-
0033920430
-
Rapid colchicine competition-binding scintillation proximity assay using biotin-labeled tubulin
-
Tahir SK, Kovar P, Rosenberg SH, Ng SC. Rapid colchicine competition-binding scintillation proximity assay using biotin-labeled tubulin. Biotechniques 2000, 29(1):156-160.
-
(2000)
Biotechniques
, vol.29
, Issue.1
, pp. 156-160
-
-
Tahir, S.K.1
Kovar, P.2
Rosenberg, S.H.3
Ng, S.C.4
-
25
-
-
0018818340
-
Inhibition of tubulin polymerization by mebendazole
-
10.1016/0006-291X(80)90349-6, 7356473
-
Laclette JP, Guerra G, Zetina C. Inhibition of tubulin polymerization by mebendazole. Biochem Biophys Res Commun 1980, 92(2):417-423. 10.1016/0006-291X(80)90349-6, 7356473.
-
(1980)
Biochem Biophys Res Commun
, vol.92
, Issue.2
, pp. 417-423
-
-
Laclette, J.P.1
Guerra, G.2
Zetina, C.3
-
26
-
-
2542603198
-
Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin
-
10.1021/bi036112v, 15157098
-
Gupta K, Bishop J, Peck A, Brown J, Wilson L, Panda D. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. Biochemistry 2004, 43(21):6645-6655. 10.1021/bi036112v, 15157098.
-
(2004)
Biochemistry
, vol.43
, Issue.21
, pp. 6645-6655
-
-
Gupta, K.1
Bishop, J.2
Peck, A.3
Brown, J.4
Wilson, L.5
Panda, D.6
-
27
-
-
57449091909
-
Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin
-
10.1021/bi801136q, 19049291
-
Clement MJ, Rathinasamy K, Adjadj E, Toma F, Curmi PA, Panda D. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin. Biochemistry 2008, 47(49):13016-13025. 10.1021/bi801136q, 19049291.
-
(2008)
Biochemistry
, vol.47
, Issue.49
, pp. 13016-13025
-
-
Clement, M.J.1
Rathinasamy, K.2
Adjadj, E.3
Toma, F.4
Curmi, P.A.5
Panda, D.6
-
28
-
-
0034528890
-
2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate
-
Pribluda VS, Gubish ER, Lavallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 2000, 19(1-2):173-179.
-
(2000)
Cancer Metastasis Rev
, vol.19
, Issue.1-2
, pp. 173-179
-
-
Pribluda, V.S.1
Gubish, E.R.2
Lavallee, T.M.3
Treston, A.4
Swartz, G.M.5
Green, S.J.6
-
29
-
-
71949100927
-
Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole
-
Chu SW, Badar S, Morris DL, Pourgholami MH. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. Anticancer Res 2009, 29(10):3791-3796.
-
(2009)
Anticancer Res
, vol.29
, Issue.10
, pp. 3791-3796
-
-
Chu, S.W.1
Badar, S.2
Morris, D.L.3
Pourgholami, M.H.4
-
30
-
-
0029155318
-
Kinetic stabilization of microtubule dynamics at steady state in vitro by substoichiometric concentrations of tubulin-colchicine complex
-
10.1021/bi00031a014, 7632691
-
Panda D, Daijo JE, Jordan MA, Wilson L. Kinetic stabilization of microtubule dynamics at steady state in vitro by substoichiometric concentrations of tubulin-colchicine complex. Biochemistry 1995, 34(31):9921-9929. 10.1021/bi00031a014, 7632691.
-
(1995)
Biochemistry
, vol.34
, Issue.31
, pp. 9921-9929
-
-
Panda, D.1
Daijo, J.E.2
Jordan, M.A.3
Wilson, L.4
-
31
-
-
0015102930
-
Are cytoplasmic microtubules heteropolymers?
-
10.1073/pnas.68.8.1762, 389288, 5288762
-
Bryan J, Wilson L. Are cytoplasmic microtubules heteropolymers?. Proc Natl Acad Sci USA 1971, 68(8):1762-1766. 10.1073/pnas.68.8.1762, 389288, 5288762.
-
(1971)
Proc Natl Acad Sci USA
, vol.68
, Issue.8
, pp. 1762-1766
-
-
Bryan, J.1
Wilson, L.2
-
32
-
-
0029360519
-
Microtubule dynamics: taking aim at a moving target
-
10.1016/1074-5521(95)90119-1, 9383460
-
Wilson L, Jordan MA. Microtubule dynamics: taking aim at a moving target. Chem Biol 1995, 2(9):569-573. 10.1016/1074-5521(95)90119-1, 9383460.
-
(1995)
Chem Biol
, vol.2
, Issue.9
, pp. 569-573
-
-
Wilson, L.1
Jordan, M.A.2
-
33
-
-
0034595187
-
Suppression of microtubule dynamic instability and treadmilling by deuterium oxide
-
10.1021/bi992217f, 10819973
-
Panda D, Chakrabarti G, Hudson J, Pigg K, Miller HP, Wilson L, Himes RH. Suppression of microtubule dynamic instability and treadmilling by deuterium oxide. Biochemistry 2000, 39(17):5075-5081. 10.1021/bi992217f, 10819973.
-
(2000)
Biochemistry
, vol.39
, Issue.17
, pp. 5075-5081
-
-
Panda, D.1
Chakrabarti, G.2
Hudson, J.3
Pigg, K.4
Miller, H.P.5
Wilson, L.6
Himes, R.H.7
-
34
-
-
0034071993
-
Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergy
-
Giannakakou P, Fojo T. Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergy. Clin Cancer Res 2000, 6(5):1613-1615.
-
(2000)
Clin Cancer Res
, vol.6
, Issue.5
, pp. 1613-1615
-
-
Giannakakou, P.1
Fojo, T.2
-
35
-
-
84874043012
-
Microtubule: a novel target for cancer therapies
-
Goyal SS, Patel RM, Sukhramani PS, Kamothi KA. Microtubule: a novel target for cancer therapies. IJPSR 2010, 1(4):1-21.
-
(2010)
IJPSR
, vol.1
, Issue.4
, pp. 1-21
-
-
Goyal, S.S.1
Patel, R.M.2
Sukhramani, P.S.3
Kamothi, K.A.4
-
36
-
-
0026645572
-
Kinetics of colchicine binding to purified beta-tubulin isotypes from bovine brain
-
Banerjee A, Luduena RF. Kinetics of colchicine binding to purified beta-tubulin isotypes from bovine brain. J Biol Chem 1992, 267(19):13335-13339.
-
(1992)
J Biol Chem
, vol.267
, Issue.19
, pp. 13335-13339
-
-
Banerjee, A.1
Luduena, R.F.2
-
37
-
-
3543092021
-
Pathways of apoptotic and non-apoptotic death in tumour cells
-
10.1038/nrc1412, 15286739
-
Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004, 4(8):592-603. 10.1038/nrc1412, 15286739.
-
(2004)
Nat Rev Cancer
, vol.4
, Issue.8
, pp. 592-603
-
-
Okada, H.1
Mak, T.W.2
-
38
-
-
57049119555
-
Targeting apoptosis: selected anticancer strategies
-
10.1038/nrd2662, 19043447
-
Storey S. Targeting apoptosis: selected anticancer strategies. Nat Rev Drug Discov 2008, 7(12):971-972. 10.1038/nrd2662, 19043447.
-
(2008)
Nat Rev Drug Discov
, vol.7
, Issue.12
, pp. 971-972
-
-
Storey, S.1
-
39
-
-
44849106825
-
TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells
-
10.1158/0008-5472.CAN-08-0014, 18451172
-
Kim M, Liao J, Dowling ML, Voong KR, Parker SE, Wang S, El-Deiry WS, Kao GD. TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells. Cancer Res 2008, 68(9):3440-3449. 10.1158/0008-5472.CAN-08-0014, 18451172.
-
(2008)
Cancer Res
, vol.68
, Issue.9
, pp. 3440-3449
-
-
Kim, M.1
Liao, J.2
Dowling, M.L.3
Voong, K.R.4
Parker, S.E.5
Wang, S.6
El-Deiry, W.S.7
Kao, G.D.8
-
40
-
-
2642689658
-
Proteases to die for
-
10.1101/gad.12.11.1551, 9620844
-
Cryns V, Yuan J. Proteases to die for. Genes Dev 1998, 12(11):1551-1570. 10.1101/gad.12.11.1551, 9620844.
-
(1998)
Genes Dev
, vol.12
, Issue.11
, pp. 1551-1570
-
-
Cryns, V.1
Yuan, J.2
-
41
-
-
0030702084
-
Caspases: intracellular signaling by proteolysis
-
10.1016/S0092-8674(00)80430-4, 9390553
-
Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997, 91(4):443-446. 10.1016/S0092-8674(00)80430-4, 9390553.
-
(1997)
Cell
, vol.91
, Issue.4
, pp. 443-446
-
-
Salvesen, G.S.1
Dixit, V.M.2
-
42
-
-
0033861952
-
Death and decoy receptors and p53-mediated apoptosis
-
10.1038/sj.leu.2401865, 10942251
-
Sheikh MS, Fornace AJ. Death and decoy receptors and p53-mediated apoptosis. Leukemia 2000, 14(8):1509-1513. 10.1038/sj.leu.2401865, 10942251.
-
(2000)
Leukemia
, vol.14
, Issue.8
, pp. 1509-1513
-
-
Sheikh, M.S.1
Fornace, A.J.2
-
43
-
-
0033974084
-
Molecular determinants of response to TRAIL in killing of normal and cancer cells
-
el-Deiry WS
-
Kim K, Fisher MJ, Xu SQ, . el-Deiry WS Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 2000, 6(2):335-346. el-Deiry WS.
-
(2000)
Clin Cancer Res
, vol.6
, Issue.2
, pp. 335-346
-
-
Kim, K.1
Fisher, M.J.2
Xu, S.Q.3
-
44
-
-
0035863523
-
Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels
-
Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 2001, 61(2):759-763.
-
(2001)
Cancer Res
, vol.61
, Issue.2
, pp. 759-763
-
-
Nimmanapalli, R.1
Perkins, C.L.2
Orlando, M.3
O'Bryan, E.4
Nguyen, D.5
Bhalla, K.N.6
-
45
-
-
0036184739
-
Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460
-
Huisman C, Ferreira CG, Broker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Clin Cancer Res 2002, 8(2):596-606.
-
(2002)
Clin Cancer Res
, vol.8
, Issue.2
, pp. 596-606
-
-
Huisman, C.1
Ferreira, C.G.2
Broker, L.E.3
Rodriguez, J.A.4
Smit, E.F.5
Postmus, P.E.6
Kruyt, F.A.7
Giaccone, G.8
-
46
-
-
0033083990
-
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
-
Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 1999, 59(3):734-741.
-
(1999)
Cancer Res
, vol.59
, Issue.3
, pp. 734-741
-
-
Keane, M.M.1
Ettenberg, S.A.2
Nau, M.M.3
Russell, E.K.4
Lipkowitz, S.5
-
47
-
-
0037439693
-
2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway
-
LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS. 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res 2003, 63(2):468-475.
-
(2003)
Cancer Res
, vol.63
, Issue.2
, pp. 468-475
-
-
LaVallee, T.M.1
Zhan, X.H.2
Johnson, M.S.3
Herbstritt, C.J.4
Swartz, G.5
Williams, M.S.6
Hembrough, W.A.7
Green, S.J.8
Pribluda, V.S.9
|